MARCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Marcaine, and when can generic versions of Marcaine launch?
Marcaine is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in MARCAINE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MARCAINE?
- What are the global sales for MARCAINE?
- What is Average Wholesale Price for MARCAINE?
Summary for MARCAINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 124 |
Clinical Trials: | 282 |
Patent Applications: | 5,605 |
Drug Prices: | Drug price information for MARCAINE |
What excipients (inactive ingredients) are in MARCAINE? | MARCAINE excipients list |
DailyMed Link: | MARCAINE at DailyMed |
Recent Clinical Trials for MARCAINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | Phase 2/Phase 3 |
Pacira Pharmaceuticals, Inc | Phase 2/Phase 3 |
Hartford Hospital | Phase 4 |
Pharmacology for MARCAINE
Drug Class | Amide Local Anesthetic |
Physiological Effect | Local Anesthesia |